Cigna Corporation ($CI) Stock Forecast: Down 5.3% Today

What is Cigna Corporation?

Cigna Group (CI) is a leading global health services company that offers insurance and health-related products. The overall market sentiment for CI was bearish today.

Why is Cigna Corporation going down?

CI stock is down 5.3% on Mar 3, 2026 16:06

• CI experienced a bearish movement likely due to the announcement of CEO David Cordani stepping down and COO Brian Evanko taking over. This leadership transition could have caused uncertainty and concerns among investors about the company's future direction.
• Additionally, the ex-dividend trading may have contributed to the stock's decline, with investors adjusting their positions ahead of the lower opening price.
• The news of Elevance facing Medicare Advantage sanctions could have added to the negative sentiment around healthcare-related stocks, indirectly impacting CI's performance.
• Despite the bearish movement, analysts at B. Riley adjusting the price target on Cleveland-Cliffs to $16 from $14 and maintaining a "Buy" rating on the stock indicates positive outlook for the steel producer, contrasting with CI's decline.

CI Price Chart

CI Technical Analysis

CI News

Ex-Dividend Reminder: Eversource Energy, The Cigna Group and American Assets Trust

Eversource Energy (ES), The Cigna Group (CI), and American Assets Trust Inc (AAT) are scheduled to trade ex-dividend on March 5, 2026. Investors can expect their stock prices to open lower by 1.06%, 0.54%, and 1.73% respectively, reflecting the quarterly dividend payouts. While dividends are not guaranteed, the article outlines the upcoming dividend amounts and historical data to help investors assess the stability and potential future yields of these companies.

https://www.nasdaq.com/articles/ex-dividend-reminder-eversource-energy-cigna-group-and-american-assets-trust

CMS threatens Elevance with Medicare Advantage sanctions

The federal government is planning to suspend enrollment in Elevance's Medicare Advantage (MA) plans starting March 31 due to the company's failure to comply with federal data submission requirements. Elevance repeatedly submitted data via flash drives instead of electronic systems, leading to auditing and data integrity risks, and did not correct this "substantial and persistent" noncompliance despite warnings. The sanctions, which could significantly impact Elevance's finances and reputation, will remain until the insurer corrects its data submission practices.

https://www.healthcaredive.com/news/elevance-medicare-advantage-sanctions-cms-suspend-enrollment/813522/

B. Riley Adjusts Price Target on Cleveland-Cliffs to $16 From $14, Maintains Buy Rating

B. Riley has increased its price target for Cleveland-Cliffs Inc. (NYSE: CLF) to $16 from $14, while reiterating a "Buy" rating on the stock. This adjustment comes despite recent news indicating the company's Q4 revenue missed estimates. Cleveland-Cliffs is a North American flat-rolled steel producer and iron ore pellet manufacturer, serving various markets including automotive and infrastructure.

https://www.marketscreener.com/news/b-riley-adjusts-price-target-on-cleveland-cliffs-to-16-from-14-maintains-buy-rating-ce7e5cd2d88ef32d

Cigna Lines Up COO Evanko to Succeed Long-Time CEO Cordani

Cigna Group's CEO David Cordani is stepping down on July 1st, to be replaced by COO Brian Evanko, who has been considered the successor for some time. Evanko will lead a major business model pivot for the insurer, responding to government pressure to control healthcare costs. Cordani will transition to an executive chair role.

https://www.bloomberg.com/news/articles/2026-03-03/cigna-s-evanko-to-replace-cordani-as-chief-executive-officer

Empire Life taps Teladoc to support unpaid caregivers in Canada’s workforce

Empire Life has partnered with Teladoc Health Canada to launch a new caregiver support program, effective March 1, for its group benefits members. This program, integrated at no extra cost, aims to alleviate the mental and administrative burdens faced by unpaid caregivers in Canada's workforce by providing expert navigation and access to specialized support. The initiative highlights a growing industry recognition of caregiver strain as a significant workforce risk that impacts employee productivity and well-being.

https://www.insurancebusinessmag.com/ca/news/technology/empire-life-taps-teladoc-to-support-unpaid-caregivers-in-canadas-workforce-567163.aspx

Trending Today

Saia Inc. ($SAIA) Stock Forecast: Up 5.3% Today

Avis Budget Group Inc. ($CAR) Stock Forecast: Up 5.6% Today

Charles Schwab Corporation (The) ($SCHW) Stock Forecast: Down 2.5% Today

VeriSign Inc. ($VRSN) Stock Forecast: Up 5.0% Today

Plug Power Inc. ($PLUG) Stock Forecast: Up 5.7% Today

IPG Photonics Corporation ($IPGP) Stock Forecast: Down 5.1% Today

Super Micro Computer Inc ($SMCI) Stock Forecast: Down 5.0% Today

Lucid Motors Inc. ($LCID) Stock Forecast: Down 6.2% Today

Tesla Inc. ($TSLA) Stock Forecast: Down 5.1% Today

Groupon Inc. ($GRPN) Stock Forecast: Up 5.2% Today

Cigna Corporation Price History

07.00.2026 - CI Stock was down 3.1%

• The bearish movement in CI's stock could be attributed to negative developments impacting major healthcare conglomerates like CVS, UnitedHealth, and Cigna, accused of financial misconduct through secretive PBM Group Purchasing Organizations (GPOs).
• Concerns about ethical standards and financial transparency within the health insurance industry, prompted by the exposure of these practices, led to a loss in investor confidence and a decline in CI's stock price.
• The investigation revealing how these companies allegedly mishandle funds meant for health plans and patients raised worries about potential regulatory consequences and the sustainability of CI’s business model.
• Distrust and scrutiny towards the healthcare giants involved in questionable practices overshadowed CI's stock performance, contributing to the observed bearish trend.

02.00.2026 - CI Stock was up 1.8%

• The bullish movement in CI stock today could be attributed to positive news surrounding a new deal between Cigna and Tenet Healthcare Corp in Florida. This deal ensures continued in-network access for policyholders, potentially avoiding higher out-of-network costs and boosting investor confidence in CI.
• The inclusion of healthcare stocks, like CI, in a list of top 10 stock picks by a major financial institution, emphasizing diverse catalysts such as healthcare legislation, may have also contributed to the positive market sentiment in the healthcare sector.
• Despite certain pressures on another healthcare stock, CI's bullish movement today might suggest that investors perceive it to be better positioned to address challenges related to Medicare Advantage and rising medical costs effectively.
• The favorable outlook for healthcare stocks, supported by recommendations and market performance, likely influenced the bullish movement observed in CI today.

05.00.2026 - CI Stock was up 1.8%

• The bullish movement in CI's stock could be attributed to positive comments made by a hedge fund manager regarding another healthcare company, highlighting its undervaluation and long-term growth potential. This optimistic outlook on a competitor in the insurance industry may have positively impacted CI's stock.
• Additionally, the overall positive performance of managed-care peers, with a focus on upcoming earnings reports and operational reviews, could have created a favorable sentiment in the healthcare sector, benefiting CI as well.
• The resignation of a board member from another company may have had a minimal impact on CI's market movement, as investors were more likely focused on the positive news and outlook within the healthcare industry.
• A financial institution's top stock picks for Q1 2026, particularly in the healthcare sector, with diverse catalysts and strong performance indicators, could have further boosted investor confidence in CI and contributed to its bullish movement.

03.02.2026 - CI Stock was down 5.9%

• The bearish movement in Cigna Group's stock (CI) today can be attributed to the threat of Medicare Advantage sanctions faced by Elevance. This development could potentially impact CI's financials indirectly, raising concerns about compliance and regulatory risks in the healthcare industry.
• Additionally, the news of RBC increasing the price target on PACS Group (PACS) might have shifted investor focus away from CI, leading to negative sentiment towards the stock.
• The participation of CI's CFO and President of Evernorth Care Management in the TD Cowen Health Care Conference may have failed to impress investors, especially given the broader industry challenges highlighted by the Elevance sanctions.
• Overall, regulatory concerns, competitive market dynamics, and investor sentiment towards peer companies could have contributed to the bearish movement in CI's stock today.

03.02.2026 - CI Stock was down 5.3%

• CI experienced a bearish movement likely due to the announcement of CEO David Cordani stepping down and COO Brian Evanko taking over. This leadership transition could have caused uncertainty and concerns among investors about the company's future direction.
• Additionally, the ex-dividend trading may have contributed to the stock's decline, with investors adjusting their positions ahead of the lower opening price.
• The news of Elevance facing Medicare Advantage sanctions could have added to the negative sentiment around healthcare-related stocks, indirectly impacting CI's performance.
• Despite the bearish movement, analysts at B. Riley adjusting the price target on Cleveland-Cliffs to $16 from $14 and maintaining a "Buy" rating on the stock indicates positive outlook for the steel producer, contrasting with CI's decline.

04.01.2026 - CI Stock was up 1.6%

• The bullish movement in CI's stock could be attributed to the negative financial headwinds faced by major healthcare players like UnitedHealth, CVS, and Humana. As these competitors face profit pressures from proposed Medicare cuts and new regulations impacting their business segments, investors might see Cigna as a more stable and potentially profitable investment option within the healthcare sector.
• The dual pressure on UnitedHealth, CVS, and Humana from negligible Medicare Advantage payment increases and demands for transparency from PBMs could lead investors to seek alternative healthcare stocks like CI, driving up its value.
• With the potential squeeze on profits for competitors due to regulatory changes, investors may view CI as a more attractive investment opportunity, leading to the bullish movement in the stock price today.

02.04.2025 - CI Stock was down 2.1%

• The strong Q1 earnings and increased outlook suggest that Cigna's growth platforms are performing well.
• The bearish movement in the stock could be attributed to profit-taking by investors following a period of strong performance.
• Market sentiment may have been influenced by external factors or concerns about future growth potential despite the positive earnings.
• Some investors may have anticipated even higher earnings or guidance, prompting a sell-off in the stock.

05.01.2026 - CI Stock was up 0.4%

• Cigna Group's bullish momentum may stem from its positive earnings release, outperforming revenue and EPS expectations, indicating robust financial performance.
• The resolution of Express Scripts' issues with the FTC concerning insulin pricing practices might have enhanced investor trust in Cigna's dedication to ethical business conduct and cost-saving initiatives.
• Despite varied earnings results from other market players, Cigna's strategic direction and emphasis on cutting drug expenses appear to have resonated positively with investors, propelling the upward movement in its stock.

31.00.2025 - CI Stock was up 6.0%

• Despite reporting lower-than-expected earnings for Q4, Cigna's stock experienced a bullish movement.
• The positive market reaction may be linked to the company's proactive approach to addressing the earnings miss and implementing corrective measures.
• Investors seem to be optimistic about the revenue beat, indicating growth potential for Cigna in the future.
• The uptick in the stock price could be influenced by general market sentiment or external factors benefiting the healthcare sector.

06.01.2026 - CI Stock was up 5.1%

• CI stock had a strong bullish movement today, potentially driven by:
• Positive sentiment from a Discounted Cash Flow analysis suggesting the stock is undervalued by 66.7%.
• Despite facing challenges in the healthcare industry, such as regulatory scrutiny and declining operating margins, CI's undervaluation and lower-than-average P/E ratio may have attracted investors looking for a bargain.
• The decision by Molina Healthcare to retreat from certain Medicare Advantage plans could have redirected investor interest towards other healthcare companies like Cigna Group, contributing to the bullish movement.

06.00.2026 - CI Stock was down 0.0%

• Stanley Laman Group Ltd. selling a significant portion of its holdings in Healthcare Services Group, Inc. (HCSG) might have raised concerns about the overall healthcare sector, impacting CI negatively.
• Positive comments on Molina Healthcare, Inc. (MOH) as a potentially undervalued player in the industry could have shifted investor focus away from CI.
• UnitedHealth Group Incorporated's positive performance and upcoming earnings report may have drawn attention and investment away from CI, contributing to its bearish movement.
• The resignation of Andrew Teno from Southwest Gas Holdings Inc. (SWX) board might have had a minor indirect impact on CI, as it could have influenced market sentiment towards related healthcare stocks.

03.09.2025 - CI Stock was up 4.7%

• The uptick in short interest may suggest a pessimistic outlook on Cigna Group among investors.
• Despite the growth in short interest, there is a sense of optimism regarding the company's future growth prospects and profitability.
• The positive movement in CI's stock price today could be connected to strong earnings results or strategic business advancements that have inspired confidence in investors.
• The market may be reevaluating the company's worth and potential for growth, leading to heightened buying activity and an increase in the stock price.